Shanghai Obio Technology (Group) (SHSE:688238) Other Financing: ¥-41.7 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688238 Shanghai Obio Technology (Group) Corp Ltd SHSE:688238
65 GF Score
Price ¥5.52
GF Value ¥7.86
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Shanghai Obio Technology (Group) Other Financing?

Shanghai Obio Technology (Group) SHSE:688238 -2.65% 65 Other Financing is ¥-41.7 Mil as of Mar. 2026. GuruFocus rates SHSE:688238 with a GF Score™ of 65/100 and a GF Value™ of ¥7.86 (Possible Value Trap). The stock has 5 warning signs investors should review.

Shanghai Obio Technology (Group)'s Other Financing for the three months ended in Mar. 2026 was ¥1.6 Mil.

Shanghai Obio Technology (Group)'s Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-41.7 Mil.

Shanghai Obio Technology (Group) Other Financing Historical Data

* Premium members only.

The historical data trend for Shanghai Obio Technology (Group)'s Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Obio Technology (Group) Other Financing Chart

Shanghai Obio Technology (Group) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.45 1,150.03 33.07 -0.23 -101.80

Shanghai Obio Technology (Group) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.49 -41.65 -1.60 -0.06 1.58
SHSE:688238
65GF Score
Shanghai Obio Technology (Group) Corp Ltd SHSE:688238
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Obio Technology (Group) Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-41.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ¥-41.7 Mil mean?
Shanghai Obio Technology (Group) (SHSE:688238) has a Other Financing of ¥-41.7 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Shanghai Obio Technology (Group) and its competitors.
Is Shanghai Obio Technology (Group)'s Other Financing too high?
Shanghai Obio Technology (Group)'s current Other Financing is ¥-41.7 Mil. Overall, Shanghai Obio Technology (Group) has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Obio Technology (Group)'s Other Financing compare to VRTX and REGN?
Shanghai Obio Technology (Group)'s Other Financing of ¥-41.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Shanghai Obio Technology (Group) and its competitors. Shanghai Obio Technology (Group)'s current Other Financing is ¥-41.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Obio Technology (Group) stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Obio Technology (Group) (SHSE:688238) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.86, compared to a current price of ¥5.52 — trading 29.8% below its estimated fair value. The current Other Financing is ¥-41.7 Mil. Shanghai Obio Technology (Group)'s overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Shanghai Obio Technology (Group) (SHSE:688238), the current Other Financing is ¥-41.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Obio Technology (Group) (SHSE:688238) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Obio Technology (Group) stock appears to be undervalued. The current stock price of ¥5.52 is trading 29.8% below its estimated GF Value™ of ¥7.86. GuruFocus considers Shanghai Obio Technology (Group) to be Possible Value Trap.

Key valuation signals for SHSE:688238:

  • Other Financing: ¥-41.7 Mil
  • GF Value™: ¥7.86 vs. price of ¥5.52 (29.8% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688238 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Obio Technology (Group) Business Description

Address Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201318
Shanghai Obio Technology (Group) Corp Ltd provides contract research organization (CRO) services, including gene therapy vector development and gene function research for basic research, as well as contract development and manufacturing organization (CDMO) services, including IND-enabling CMC research and GMP production of clinical samples for gene therapy drug development.
65GF Score

Get the complete analysis for SHSE:688238

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.52
Price
¥7.86
GF Value